Skip to main content
Clinical Trials/NCT00177567
NCT00177567
Completed
Phase 4

Treatment of Geriatric Bipolar Mood Disorders: A Pilot Study

University of Pittsburgh2 sites in 1 country60 target enrollmentJuly 2001

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Bipolar Disorder
Sponsor
University of Pittsburgh
Enrollment
60
Locations
2
Primary Endpoint
The percent of subjects remitting from their index affective episode, the time to remission, the percent of partially and non-remitting patients, the incidence of relapse during continuation treatment, and of recurrence during maintenance treatment
Status
Completed
Last Updated
20 years ago

Overview

Brief Summary

The purpose of this study is to collect pilot data on the feasibility of recruiting, eliciting informed consent, assessing, treating, and following patients aged 60 and older with bipolar mood disorders.

Detailed Description

Study specific aims are: * to establish a recruitment, referral, and collaborative network for elderly bipolar patients, in collaboration with the NIMH funded STEP-BD * to establish an outpatient treatment clinic at the Bellefield Towers site of the NIMH funded Intervention Research Center for Late Life Mood Disorders * to implement standardized care pathways compatible with STEP-BD treatment algorithms for mood stabilizing pharmacotherapy. * to document short- and long-term treatment response with respect to affective symptoms, sleep, general life functioning, cognition, treatment-emergent side effects * to establish the clinical infrastructure necessary for randomized controlled clinical trials and for clinical research training in bipolar mood disorders of late-life.

Registry
clinicaltrials.gov
Start Date
July 2001
End Date
January 2004
Last Updated
20 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • DSM-IV diagnosis of Bipolar Disorder
  • Folstein Mini-Mental Status Exam score of 18 or higher

Exclusion Criteria

  • Medical condition that precludes the use of both lithium and depakote
  • If mood disturbance is deemed an organic mood disorder (i.e., iatrogenic, secondary to medication)
  • If refuse to designate someone who the study staff can contact about bipolar symptoms, concerns about the subject's health, in an emergency, and/or inability to reach the subject.

Outcomes

Primary Outcomes

The percent of subjects remitting from their index affective episode, the time to remission, the percent of partially and non-remitting patients, the incidence of relapse during continuation treatment, and of recurrence during maintenance treatment

Secondary Outcomes

  • Measures of affective symptoms, functional status, side effects, and cognition tracked over acute, continuation, and maintenance phases of treatment.

Study Sites (2)

Loading locations...

Similar Trials